Efficacy of intraoperative ketamine/esketamine in the prevention of postoperative delirium: a systematic review and meta-analysis
Wirksamkeit von intraoperativem Ketamin/Esketamin zur Prävention eines postoperativen Delirs: systematische Übersicht und Metaanalyse
Therapeutic Advances in Psychopharmacology · 2025-09 · 15
DOI: 10.1177/20451253251339378 ↗Auf einen Blick
18 Studien mit 1.571 Teilnehmenden zeigen: Intraoperatives Ketamin/Esketamin war mit weniger postoperativem Delir verbunden. Esketamin und subanästhetische Dosen wirkten stärker.
Fragestellung
Verringert intraoperatives Ketamin/Esketamin die Inzidenz eines postoperativen Delirs nach Allgemeinanästhesie?
Methode
Systematische Übersicht und Metaanalyse nach PRISMA; Suche in PubMed, Embase, Medline (Ovid), Cochrane, Scopus und Web of Science bis 10. Juli 2024. Effektmaß war RR mit 95 %-KI; Heterogenität mit I2 geprüft.
Ergebnisse
18 Studien mit 1.571 Teilnehmenden. POD: RR 0,71 (95 %-KI 0,56–0,90; p < 0,01). Esketamin vs. Ketamin: RR 0,59 (95 %-KI 0,38–0,90; p = 0,02). ⩽0,5 mg/kg: RR 0,52 (95 %-KI 0,34–0,79; p < 0,01).
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass Ketamin/Esketamin perioperativ einen schützenden Effekt gegen POD hatte, wobei Esketamin wirksamer war als Ketamin. Subanästhetische Dosen zeigten die größere Wirksamkeit.
Kernaussagen
- Weniger POD unter Ketamin/Esketamin: RR 0,71
- Esketamin war wirksamer als Ketamin
- Subanästhetische Dosen zeigten den stärkeren Effekt
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 20.09.2025. Verfasst von Chengchuan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Delir
Abstract (Originalsprache)
Background
Postoperative delirium (POD) is associated with higher risks of postoperative complications and mortality (2- to 3-fold increase). Studies investigating the effect of intraoperative ketamine on POD risk have yielded conflicting results. This study aimed to assess the effects of intraoperative ketamine and its more potent version, esketamine, on POD.
Design
Systematic review and meta-analysis.
Objective
To evaluate the effect of intraoperative ketamine/esketamine on the incidence of POD.
Methods
We adhered to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, and searched the PubMed, Embase, Medline (Ovid), Cochrane, Scopus, and Web of Science databases for the MeSH terms “ketamine” and “emergence delirium” from database inception to July 10, 2024. The primary outcome was POD incidence following general anesthesia. Data were analyzed using a common effects model, with between-study heterogeneity tested using the I 2 statistic, and relative risk (RR) with 95% confidence intervals (CIs) for dichotomous data was used as the effect measure.
Results
A total of 18 studies with a total of 1571 participants met eligibility criteria. A meta-analysis of all studies suggests that the intraoperative use of ketamine/esketamine may reduce the incidence of POD (RR = 0.71, 95% CI: 0.56, 0.90, p < 0.01). In the drug subgroup, esketamine demonstrated enhanced efficacy in preventing POD compared to ketamine (RR = 0.59, 95% CI: 0.38, 0.90, p = 0.02). In addition, subanesthetic doses of ketamine/esketamine (⩽0.5 mg/kg) contributed to POD prevention (RR = 0.52, 95% CI: 0.34, 0.79, p < 0.01), whereas higher doses (>0.5 mg/kg) showed no statistically significant effect (RR = 0.89, 95% CI: 0.66, 1.21, p = 0.46). Further analysis revealed additional benefits of ketamine/esketamine in reducing POD incidence in cardiac surgery (RR = 0.46, 95% CI: 0.31, 0.68, p < 0.01), in the elderly (RR = 0.68, 95% CI: 0.52, 0.91, p < 0.01), and in the first 24 h post-surgery (RR = 0.52, 95% CI: 0.29, 0.94, p = 0.03).
Conclusion
Our findings suggest that perioperative administration of ketamine/esketamine had a protective effect against the incidence of POD, with esketamine demonstrating superior efficacy compared to ketamine. The treatment effect exhibited a dose-response relationship, with subanesthetic doses showing greater efficacy. Furthermore, ketamine/esketamine may offer additional benefits for patients with specific risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.
- Department of Cardiology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan Province, China.
- Department of Cardiology, The First Affiliated Hospital of Chengdu Medical College, No. 278, Baoguang Avenue, Xindu District, Chengdu 610500, China.
ORCID-Profile: Jixin Hou
Zitieren
APA
Chen, C., Zhou, N., & Hou, J. (2025). Efficacy of intraoperative ketamine/esketamine in the prevention of postoperative delirium: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 15. https://doi.org/10.1177/20451253251339378
Vancouver
Chen C, Zhou N, Hou J. Efficacy of intraoperative ketamine/esketamine in the prevention of postoperative delirium: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2025;15. doi:10.1177/20451253251339378
BibTeX
@article{Chen2025,
author = {Chen, Chengchuan and Zhou, Na and Hou, Jixin},
title = {Efficacy of intraoperative ketamine/esketamine in the prevention of postoperative delirium: a systematic review and meta-analysis},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2025},
volume = {15},
doi = {10.1177/20451253251339378}
}
EUVIMED